AI주식인사이트AI Stock Insight
C

경남제약

053950KOSDAQ의약품 제조업

54.8 / 100

Reference Date: 2026-07-24

Financial Score20.0 / 40
News Sentiment18.8 / 25
Momentum4.0 / 20
Disclosure12.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 22.9% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Gyeongnam Pharmaceutical primarily operates in the manufacturing and sales of pharmaceuticals, raw materials, and health functional foods, distributing products like Lemona, Jaha Saengryeok, and Minol. In 2025, revenue reached 55.9 billion won, a decrease of approximately 8% compared to the previous period, though the Lemona food product line continues to show steady growth. The company is expanding its business through online marketing and broadening its distribution channels.

Number of Employees

238people

Average Salary

53.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 11.234.0Point
PBR
0.23Industry Average 0.817.0Point

Half of industry avg (excellent)

ROE
-8.06Industry Average 4.010.0Point

Well below industry avg

Debt Ratio
1.01Industry Average 12.438.0Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼9.6% (2-year basis)

Operating Profit Growth Rate
1.0 / 3

Avg ▲1.2% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -7.9% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 75

Detailed Momentum

52-week position3.0Point

52w lower range (37%)

Current 1,603Won52-week high 3,35052-week low 564
1-month return0.0Point

1m -22.93% (strong drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

10 totalPositive 1Neutral 9Negative 0
  • Positive[기재정정]주요사항보고서(유상증자결정)2026-07-10
  • Neutral[기재정정]증권발행결과(자율공시)2026-07-10
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-08
  • Neutral주식등의대량보유상황보고서(일반)2026-07-08
  • Neutral타법인주식및출자증권취득결정2026-07-07